Labcorp Holdings Diagnostics — Goodwill acquired, excluding measurement period adjustments increased by 35.9% to $146.60M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2021 to FY 2024), Diagnostics — Goodwill acquired, excluding measurement period adjustments shows an upward trend with a 16.8% CAGR.
Higher values indicate an aggressive inorganic growth strategy, while lower values suggest a focus on organic growth or a pause in M&A activity.
This metric tracks the gross amount of goodwill recognized specifically from new acquisitions completed during the repor...
Used by analysts to evaluate the scale and frequency of a company's acquisition pipeline.
lh_segment_diagnostics_goodwill_acquired_excluding_measurement_period_adjustments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $61.28M | $61.28M | $61.28M | $139.48M | $139.48M | $139.48M | $139.48M | $74.23M | $74.23M | $74.23M | $74.23M | $97.63M | $97.63M | $97.63M | $97.63M | $138.80M | $107.90M | $146.60M |
| QoQ Change | — | +0.0% | +0.0% | +127.6% | +0.0% | +0.0% | +0.0% | -46.8% | +0.0% | +0.0% | +0.0% | +31.5% | +0.0% | +0.0% | +0.0% | +42.2% | -22.3% | +35.9% |
| YoY Change | — | — | — | — | +127.6% | +127.6% | +127.6% | -46.8% | -46.8% | -46.8% | -46.8% | +31.5% | +31.5% | +31.5% | +31.5% | +42.2% | +10.5% | — |